Go Pro
→ Iran War: What Happened at 1:11 P.M. Outside D.C.? (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Illumina, Inc. stock logo
ILMN
Illumina
$192.64
-0.1%		$183.21
$88.00
▼
$207.00
$29.13B1.451.98 million shs1.06 million shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$581.95
-2.5%		$533.75
$373.00
▼
$677.90
$16.66B1.15364,115 shs151,060 shs
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
$1,432.94
-0.4%		$1,287.94
$1,023.05
▼
$1,525.17
$28.82B1.23173,853 shs89,589 shs
Qiagen N.V. stock logo
QGEN
Qiagen
$43.25
+0.6%		$39.97
$32.53
▼
$57.81
$8.86B0.632.54 million shs3.18 million shs
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Illumina, Inc. stock logo
ILMN
Illumina
-0.14%-0.56%+0.75%+35.15%+90.53%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
-2.52%-0.52%+8.54%+40.14%+24.35%
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
-0.36%+0.91%+8.91%+38.61%+8.20%
Qiagen N.V. stock logo
QGEN
Qiagen
+0.69%+3.69%+3.88%+31.03%-16.58%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Illumina, Inc. stock logo
ILMN
Illumina
$192.64
-0.1%		$183.21
$88.00
▼
$207.00
$29.13B1.451.98 million shs1.06 million shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$581.95
-2.5%		$533.75
$373.00
▼
$677.90
$16.66B1.15364,115 shs151,060 shs
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
$1,432.94
-0.4%		$1,287.94
$1,023.05
▼
$1,525.17
$28.82B1.23173,853 shs89,589 shs
Qiagen N.V. stock logo
QGEN
Qiagen
$43.25
+0.6%		$39.97
$32.53
▼
$57.81
$8.86B0.632.54 million shs3.18 million shs
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Illumina, Inc. stock logo
ILMN
Illumina
-0.14%-0.56%+0.75%+35.15%+90.53%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
-2.52%-0.52%+8.54%+40.14%+24.35%
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
-0.36%+0.91%+8.91%+38.61%+8.20%
Qiagen N.V. stock logo
QGEN
Qiagen
+0.69%+3.69%+3.88%+31.03%-16.58%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Illumina, Inc. stock logo
ILMN
Illumina
2.47
Hold$188.40-2.20% Downside
Medpace Holdings, Inc. stock logo
MEDP
Medpace
2.23
Hold$584.180.38% Upside
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
2.46
Hold$1,461.271.98% Upside
Qiagen N.V. stock logo
QGEN
Qiagen
2.36
Hold$43.931.57% Upside

Current Analyst Ratings Breakdown

Latest QGEN, MTD, ILMN, and MEDP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/12/2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C+) ➝ Buy (B-)
8/10/2026
Qiagen N.V. stock logo
QGEN
Qiagen
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral$38.00 ➝ $45.00
8/7/2026
Qiagen N.V. stock logo
QGEN
Qiagen
Stifel Nicolaus logo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$40.00
8/7/2026
Qiagen N.V. stock logo
QGEN
Qiagen
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetEqual Weight$38.00 ➝ $40.00
8/7/2026
Qiagen N.V. stock logo
QGEN
Qiagen
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$45.00 ➝ $50.00
8/6/2026
Qiagen N.V. stock logo
QGEN
Qiagen
Jefferies Financial Group Inc. logo
Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$48.00
8/5/2026
Illumina, Inc. stock logo
ILMN
Illumina
Deutsche Bank Aktiengesellschaft logo
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold
8/4/2026
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C-) ➝ Hold (C)
8/4/2026
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$1,275.00 ➝ $1,450.00
8/3/2026
Illumina, Inc. stock logo
ILMN
Illumina
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetHold$190.00 ➝ $205.00
8/3/2026
Illumina, Inc. stock logo
ILMN
Illumina
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetSell$95.00 ➝ $113.00
(Data available from 8/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Illumina, Inc. stock logo
ILMN
Illumina
$4.34B6.70$6.71 per share28.73$18.80 per share10.25
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$2.53B6.42$16.58 per share35.09$15.54 per share37.45
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
$4.03B7.13$49.45 per share28.98$0.64 per share2,238.96
Qiagen N.V. stock logo
QGEN
Qiagen
$2.09B4.26$3.42 per share12.63$17.89 per share2.42
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Illumina, Inc. stock logo
ILMN
Illumina
$850M$5.3635.9431.682.7118.36%29.84%12.17%10/29/2026 (Estimated)
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$451.12M$17.0634.1130.362.6617.67%110.15%24.84%10/28/2026 (Estimated)
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
$869.19M$44.4332.2527.412.9621.91%-1,212.14%25.11%N/A
Qiagen N.V. stock logo
QGEN
Qiagen
$424.88M$1.9522.1615.904.2819.49%14.24%8.23%N/A

Latest QGEN, MTD, ILMN, and MEDP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2026Q2 2026
Qiagen N.V. stock logo
QGEN
Qiagen
$0.5980$0.62+$0.0220$0.50$527.50 million$535.04 million
7/31/2026Q2 2026
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
$10.78$11.46+$0.68$11.55$1.03 billion$1.03 billion
7/30/2026Q2 2026
Illumina, Inc. stock logo
ILMN
Illumina
$1.23$1.31+$0.08$1.35$1.13 billion$1.16 billion
7/22/2026Q2 2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$3.98$4.25+$0.27$4.25$689.51 million$707.33 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Illumina, Inc. stock logo
ILMN
Illumina
N/AN/AN/AN/AN/A
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/AN/AN/AN/AN/A
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
N/AN/AN/AN/AN/A
Qiagen N.V. stock logo
QGEN
Qiagen
$0.350.81%N/A17.95%N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Illumina, Inc. stock logo
ILMN
Illumina
0.53
1.80
1.40
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/A
0.73
0.73
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
159.45
1.12
0.78
Qiagen N.V. stock logo
QGEN
Qiagen
0.49
3.21
2.57

Institutional Ownership

CompanyInstitutional Ownership
Illumina, Inc. stock logo
ILMN
Illumina
89.42%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
77.98%
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
95.07%
Qiagen N.V. stock logo
QGEN
Qiagen
70.00%

Insider Ownership

CompanyInsider Ownership
Illumina, Inc. stock logo
ILMN
Illumina
2.90%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
20.50%
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
0.71%
Qiagen N.V. stock logo
QGEN
Qiagen
9.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Illumina, Inc. stock logo
ILMN
Illumina
8,650151.00 million146.62 millionOptionable
Medpace Holdings, Inc. stock logo
MEDP
Medpace
6,20027.91 million22.19 millionOptionable
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
18,10020.04 million19.90 millionOptionable
Qiagen N.V. stock logo
QGEN
Qiagen
5,654206.07 million187.53 millionOptionable

Recent News About These Companies

Qiagen (QGEN) Beat Its Own Guidance, So Why Did Margins Slip?
August 13 at 4:11 PM  |  insidermonkey.comhttps://www.insidermonkey.com/blog/qiagen-qgen-beat-its-own-guidance-so-why-did-margins-slip-1810185/
Will FDA Clearance of QIAstat-Dx Bloodstream Panel Change Qiagen's (QGEN) Syndromic Testing Narrative?
August 13 at 1:35 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/fda-clearance-qiastat-dx-bloodstream-121034829.html
Stock Traders Buy High Volume of Call Options on Qiagen (NYSE:QGEN)
August 13 at 1:21 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30957217
Analysts’ Top Healthcare Picks: Qiagen (QGEN), Establishment Labs Holdings (ESTA)
August 12 at 10:05 PM  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/QGEN/pressreleases/3802791/analysts-top-healthcare-picks-qiagen-qgen-establishment-labs-holdings-esta/
Analysts’ Top Healthcare Picks: Qiagen (QGEN), Establishment Labs Holdings (ESTA)
August 12 at 10:05 PM  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/QGEN/pressreleases/3802791/analysts-top-healthcare-picks-qiagen-qgen-establishment-labs-holdings-esta/
Qiagen Sees Unusually High Options Volume (NYSE:QGEN)
August 11 at 11:39 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/qiagen-sees-unusually-high-options-volume-nyseqgen-2026-08-11/
QIAGEN Receives U.S. FDA Clearance for First QIAstat-Dx Bloodstream Infection Panel
August 10, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260810720979/en/qiagen-receives-u.s.-fda-clearance-for-first-qiastat-dx-bloodstream-infection-panel/
Understanding Qiagen (QGEN) Reliance on International Revenue
August 10, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2971712/understanding-qiagen-qgen-reliance-on-international-revenue?cid=cs-stocknewsapi-ft-fundamental_analysis|nfm_international_revenues-2971712
Qiagen (NYSE:QGEN) Price Target Raised to $50.00
August 10, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30951417
Analysts Offer Insights on Healthcare Companies: Insmed (INSM) and Qiagen (QGEN)
August 9, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/QGEN/pressreleases/3733958/analysts-offer-insights-on-healthcare-companies-insmed-insm-and-qiagen-qgen/
63,219 Shares in Qiagen N.V. $QGEN Bought by The Manufacturers Life Insurance Company
August 9, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-63219-shares-in-qiagen-nv-qgen-bought-by-the-manufacturers-life-insurance-company-2026-08-09/
Qiagen Q2 Earnings Call Highlights
August 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/qiagen-q2-earnings-call-highlights-2026-08-08/
JPMorgan Chase & Co. Boosts Qiagen (NYSE:QGEN) Price Target to $50.00
August 7, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/jpmorgan-chase-co-boosts-qiagen-nyseqgen-price-target-to-5000-2026-08-07/
Qiagen Files U.S. GAAP Quarterly Report for Period Ended June 30, 2026
August 7, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/qiagen-files-u-s-gaap-quarterly-report-for-period-ended-june-30-2026?utm_source=marketbeat.com&utm_medium=referral
Qiagen Files Form 6-K Detailing 2026 AGM and 2025 Annual Reports
August 7, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/qiagen-files-form-6-k-detailing-2026-agm-and-2025-annual-reports?utm_source=marketbeat.com&utm_medium=referral
Quantinno Capital Management LP Has $5.30 Million Stock Holdings in Qiagen N.V. $QGEN
August 7, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-quantinno-capital-management-lp-has-530-million-stock-holdings-in-qiagen-nv-qgen-2026-08-07/
Qiagen N.V. (NYSE:QGEN) Given Average Rating of "Hold" by Analysts
August 7, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/qiagen-nv-nyseqgen-given-average-rating-of-hold-by-analysts-2026-08-07/
Bank of America Corp DE Sells 418,992 Shares of Qiagen N.V. $QGEN
August 7, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-bank-of-america-corp-de-sells-418992-shares-of-qiagen-nv-qgen-2026-08-07/
Qiagen (NYSE:QGEN) Updates Q3 2026 Earnings Guidance
August 6, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/qiagen-nyseqgen-updates-q3-2026-earnings-guidance-2026-08-06/
Qiagen N.V. (QGEN) Q2 2026 Earnings Call Transcript
August 6, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4931954-qiagen-n-v-qgen-q2-2026-earnings-call-transcript
Qiagen N.V. 2026 Q2 - Results - Earnings Call Presentation
August 6, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4931856-qiagen-n-v-2026-q2-results-earnings-call-presentation

New MarketBeat Followers Over Time

Media Sentiment Over Time

Illumina stock logo

Illumina NASDAQ:ILMN

$192.64 -0.27 (-0.14%)
Closing price 08/13/2026 04:00 PM Eastern
Extended Trading
$193.73 +1.09 (+0.57%)
As of 08/13/2026 05:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.

Medpace stock logo

Medpace NASDAQ:MEDP

$581.95 -15.03 (-2.52%)
Closing price 08/13/2026 04:00 PM Eastern
Extended Trading
$582.22 +0.27 (+0.05%)
As of 08/13/2026 05:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

Mettler-Toledo International stock logo

Mettler-Toledo International NYSE:MTD

$1,432.94 -5.59 (-0.39%)
Closing price 08/13/2026 03:59 PM Eastern
Extended Trading
$1,431.06 -1.88 (-0.13%)
As of 08/13/2026 05:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company's retail weighing solutions consist of weighing and software solutions, AI-driven image recognition solution, and automated packaging and labelling solutions for the meat backroom. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is based in Columbus, Ohio.

Qiagen stock logo

Qiagen NYSE:QGEN

$43.25 +0.25 (+0.57%)
Closing price 08/13/2026 03:59 PM Eastern
Extended Trading
$43.24 -0.01 (-0.01%)
As of 08/13/2026 04:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas